Need professional-grade analysis? Visit stockanalysis.com
$16.57B
32.78
N/A
0.40%
Shandong Weigao Blood (603014) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY37.12, down 2.62% from the previous close.
Over the past year, 603014 has traded between a low of CNY35.44 and a high of CNY46.53. The stock has lost 10.0% over this period. It is currently 20.2% below its 52-week high.
Shandong Weigao Blood has a market capitalization of $16.57B, with a price-to-earnings ratio of 32.78 and a dividend yield of 0.40%.
Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets. The company was founded in 2004 and is based in Weihai, China.